http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008280902-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22099db0ceb5265a0acae740d69e91bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_638266629f435a50a9d07e739053957d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2af954bd26e89fc1e7c789fe4df0558e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37d703eb9c72cd38fe53b474053f9dfe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
filingDate 2006-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b481aca382c2ae2590260a59aa716b41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60998d456ae43ae3546d810d01e3f1dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c13999800d31e597c04bf9c0277643f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb01e4daf172e0a414dc7b5d93f04933
publicationDate 2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008280902-A1
titleOfInvention Inhibitors of Checkpoint Kinases
abstract The instant invention provides for compounds which comprise substituted quinolinones that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound to a patient in need of treatment of cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9633379-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8306969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010082661-A1
priorityDate 2005-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7169788-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6927293-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002041880-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004220216-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306874-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172

Total number of triples: 36.